|
参考文献
[ 1 ] Postal M,Vivaldo JF,Fernandez-Ruiz R,et al. Type I interferon in the pathogenesis of systemic lupus erythematosus[J]. Curr Opin Immunol,2020(67):87-94.
[ 2 ] Liu W,Zhang S,Wang J. IFN-γ,should not be ignored in SLE[J]. Front Immunol,2022(13):954706.
[ 3 ] Rydyznski CE,Cranert SA,Zhou JQ. Affinity maturation is impaired by natural killer cell suppression of germinal centers[J]. Cell Rep,2018,24(13):3367-3373.
[ 4 ] Soelistyoningsih D,Susianti H,Kalim H,et al. The phenotype of CD3-CD56bright and CD3-CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity[J]. Reumatologia,2022,60(4):258-265.
[ 5 ] Henriques A,Teixeira L,Inês L,et al. NK cells dysfunction in systemic lupus erythematosus:relation to disease activity[J]. Clin Rheumatol,2013,32(6):805-813.
[ 6 ] Zahran AM,Abdel-Rahim MH,Elsayh KI,et al. Natural killer and natural killer T cells in juvenile systemic lupus erythematosus:relation to disease activity and progression[J]. Arch Immunol Ther Exp (Warsz),2019,67(3):161-169.
[ 7 ] Sourour SK,Aboelenein HR,Elemam NM. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients[J]. Int J Rheum Dis, 2017,20(9):1237-1246.
[ 8 ] Li WX,Pan HF,Hu JL,et al. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus[J]. Clin Rheumatol,2010(29):315-323.
[ 9 ] 陆智敏,李霞. NK细胞特性及在系统性红斑狼疮中的作用[J].大连医科大学学报,2001,43(1):1-6.
[10] Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of svstemic ludus ervthematosus [J].Arthritis Rheum,1997,40(9):1725.
[11] Hervier B,Ribon M,Decker P. Increased concentrations of circulating soluble MHC Class I-Related Chain A (sMICA) and sMICB and modulation of plasma membrane MICA expression:potential mechanisms and correlation with natural killer cell activity in systemic lupus erythematosus[J]. Front Immunol,2021(12):633-658.
[12] Wei L,Xiang Z,Zou Y. The role of NKG2D and its ligands in autoimmune diseases:new targets for immunotherapy[J]. Int J Mol Sci,2023,24(24):17545.
[13] 赵祥格,刘佳,黄会娜,等.干扰素-α介导系统性红斑狼疮外周血CD56dimCD57+自然杀伤细胞功能的损伤[J].北京大学学报(医学版),2023,55(6):975-981.
[14] 赖瀚铃,刘爽,黄新芳,等.自然杀伤细胞的杀伤功能与系统性红斑狼疮疾病活动的相关性研究[J].上海医学,2001,44(9):681-686.
[15] Jiang J,Zhao M,Chang C,et al. Type I interferons in the pathogenesis and treatment of autoimmune diseases[J]. Clin Rev Allergy Immunol,2020,59(2):248-272.
[16] Postal M,Vivaldo JF,Fernandez-Ruiz R,et al. Type I interferon in the pathogenesis of systemic lupus erythematosus[J]. Curr Opin Immunol,2020(67):87-94.
[17] Luo S, Wang Y, Zhao M, Lu Q. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus[J]. Int Immunopharmacol,2016(40):542-549,
|